Pharma

Your Article Summary

See Latest Articles

Sanofi-aventis to acquire FOVEA, a French biopharmaceutical ophthalmology company
Sanofi-aventis, 10/02/09

Sanofi–aventis announced that it has signed a binding agreement for the acquisition of Fovea Pharmaceuticals SA. (“Fovea”) a privately held French research and development biopharmaceutical company, focused on ocular diseases.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
Takeda Pharmaceuticals North America, 12/08/09

Cerner Enters R&D Pact with University
HealthDataManagement, 12/08/09

Allos Therapeutics Announces an Agreement with Idis for a Named Patient Program for FOLOTYN (pralatrexate injection)
Allos Therapeutics, 12/07/09

 See all of M&A/Partnerships